Treatment Progress Increases Five Year Survival To 41%; Rates Compared For 10 Leading Cancers
In Brief: Garb Raps “Hostility Of Executive Branch”; Hew Considers Allowing Grants For Industry
New Mexico CBCCP Charges Contracts Terminated for “Mundane Political, Economic” Factors
“Dog And Pony Show” At FCRF For NCAB OFF
Congress Asked To Equalize Cuts, Add $20 million For Centers
ACS Says New Tax Policy Hurts Charity Funds
Study Finds Short Term Tests Predict Carcinogenicity
Trending Stories
- Trump backs off the 100% pharma tariffs ultimatum
- ASCO and Google Cloud set forth a vision for using AI to modernize health care and advance oncology
- KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- White House announces “TrumpRx,” a new prescription drug website
- The Directors: Steven Artandi and Eric Winer on how looming policy changes “reverberate” through oncology
“Even when funding gets restored and if the H-1B visa threat doesn’t materialize, it creates an environment where especially young people become uncertain.” - Lazarex Cancer Foundation set to close its doors Dec. 31
Can health nonprofits survive in the current environment?